Literature DB >> 8600417

Ganciclovir intraocular implant. A clinicopathologic study.

N C Charles1, G C Steiner.   

Abstract

BACKGROUND: Surgical implantation of the intraocular sustained-release ganciclovir device is a safe and effective treatment for cytomegalovirus (CMV) retinitis. Previous histopathologic studies on eyes containing such implants have been limited by the necessity of removing the device before processing. Microtome sectioning of hard plastics within paraffin-embedded blocks is infeasible, and the anatomic relations of implant to eye are destroyed.
METHODS: The authors studied four eyes from three patients who had undergone implant insertion. Globes with implants in place were fixed in neutral 10% formation, embedded in methylmethacrylate, sectioned on a special microtome, and stained with hematoxylin-eosin.
RESULTS: After methacrylate embedding, the precise anatomic relations of the implant to the neighboring uveoscleral coats were preserved. In two eyes, the suture tab of the implant protruded through the sclera, exiting subconjunctivally. In two eyes, the implant was totally intravitreal. In all patients, the device was supported by fibrous tissue which emanated from a surgical coloboma of the pars plana ciliaris. Focal granulomatous inflammation adjoined suture and implant materials but no other inflammation or deleterious effects on the ocular structures were noted.
CONCLUSION: This report is the first to document the intraocular histopathology of the ganciclovir implant. The subconjunctival location, enhancing the potential for endophthalmitis, may be avoided by trimming of the suture tab close to the anchoring suture and not tying it too tightly. Methylmethacrylate embedding is a useful technique for preserving the microanatomy of intraocular implants.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8600417     DOI: 10.1016/s0161-6420(96)30677-5

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  5 in total

1.  Ultrasound biomicroscopic study of sclerotomy sites after implantation of sustained release drug devices.

Authors:  S Kunimatsu; Y Fujino; Y Nagata; K Ono; M Mochizuki; J Numaga; H Kawashima; M Araie
Journal:  Br J Ophthalmol       Date:  2002-08       Impact factor: 4.638

2.  Intravenous infusion of RMP-7 increases ocular uptake of ganciclovir.

Authors:  P J Elliot; R T Bartus; J B Mackic; B V Zlokovic
Journal:  Pharm Res       Date:  1997-01       Impact factor: 4.200

3.  Analytical and Computational Modeling of Sustained-Release Drug Implants in the Vitreous Humor.

Authors:  Anahid Khoobyar; Amin Naghdloo; Anita N Penkova; Mark S Humayun; Satwindar Singh Sadhal
Journal:  J Heat Transfer       Date:  2021-09-08       Impact factor: 1.855

4.  Improved intraocular bioavailability of ganciclovir by mucoadhesive polymer based ocular microspheres: development and simulation process in Wistar rats.

Authors:  Usha Ganganahalli Kapanigowda; Sree Harsha Nagaraja; Balakeshwa Ramaiah; Prakash Rao Boggarapu
Journal:  Daru       Date:  2015-10-24       Impact factor: 3.117

5.  Electrostatically gated nanofluidic membrane for ultra-low power controlled drug delivery.

Authors:  Nicola Di Trani; Antonia Silvestri; Antons Sizovs; Yu Wang; Donald R Erm; Danilo Demarchi; Xuewu Liu; Alessandro Grattoni
Journal:  Lab Chip       Date:  2020-05-05       Impact factor: 6.799

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.